Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$0.768
-0.0320 (-4.00%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.700 $1.03 Friday, 10th May 2024 HOOK stock ended at $0.768. This is 4.00% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.46% from a day low at $0.740 to a day high of $0.81.
90 days $0.605 $1.03
52 weeks $0.410 $2.05

Historical Hookipa Pharma Inc. prices

Date Open High Low Close Volume
Nov 09, 2023 $0.460 $0.500 $0.440 $0.440 472 991
Nov 08, 2023 $0.460 $0.500 $0.460 $0.500 342 280
Nov 07, 2023 $0.492 $0.492 $0.450 $0.453 312 159
Nov 06, 2023 $0.463 $0.480 $0.463 $0.463 202 707
Nov 03, 2023 $0.440 $0.497 $0.440 $0.461 987 188
Nov 02, 2023 $0.440 $0.440 $0.415 $0.430 177 390
Nov 01, 2023 $0.430 $0.433 $0.410 $0.421 267 181
Oct 31, 2023 $0.438 $0.450 $0.421 $0.432 194 587
Oct 30, 2023 $0.460 $0.460 $0.422 $0.438 355 477
Oct 27, 2023 $0.470 $0.472 $0.425 $0.430 70 150
Oct 26, 2023 $0.443 $0.474 $0.410 $0.439 1 307 461
Oct 25, 2023 $0.456 $0.493 $0.431 $0.457 191 987
Oct 24, 2023 $0.420 $0.465 $0.420 $0.457 400 190
Oct 23, 2023 $0.481 $0.500 $0.430 $0.455 1 040 405
Oct 20, 2023 $0.495 $0.500 $0.464 $0.474 182 697
Oct 19, 2023 $0.550 $0.550 $0.462 $0.485 601 854
Oct 18, 2023 $0.540 $0.545 $0.512 $0.529 584 406
Oct 17, 2023 $0.537 $0.550 $0.523 $0.523 206 503
Oct 16, 2023 $0.532 $0.550 $0.532 $0.540 191 442
Oct 13, 2023 $0.560 $0.560 $0.540 $0.546 158 452
Oct 12, 2023 $0.565 $0.565 $0.541 $0.560 421 771
Oct 11, 2023 $0.550 $0.565 $0.550 $0.555 90 037
Oct 10, 2023 $0.559 $0.565 $0.536 $0.565 164 813
Oct 09, 2023 $0.566 $0.580 $0.550 $0.557 197 730
Oct 06, 2023 $0.570 $0.580 $0.560 $0.580 130 298
Click to get the best stock tips daily for free!

About Hookipa Pharma Inc.

Hookipa Pharma. HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-2... HOOK Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT